| Literature DB >> 29312444 |
Juan A Navarro1, Stephan Schneuwly1.
Abstract
Maintenance of metal homeostasis is crucial for many different enzymatic activities and in turn for cell function and survival. In addition, cells display detoxification and protective mechanisms against toxic accumulation of metals. Perturbation of any of these processes normally leads to cellular dysfunction and finally to cell death. In the last years, loss of metal regulation has been described as a common pathological feature in many human neurodegenerative diseases. However, in most cases, it is still a matter of debate whether such dyshomeostasis is a primary or a secondary downstream defect. In this review, we will summarize and critically evaluate the contribution of Drosophila to model human diseases that involve altered metabolism of metals or in which metal dyshomeostasis influence their pathobiology. As a prerequisite to use Drosophila as a model, we will recapitulate and describe the main features of core genes involved in copper and zinc metabolism that are conserved between mammals and flies. Drosophila presents some unique strengths to be at the forefront of neurobiological studies. The number of genetic tools, the possibility to easily test genetic interactions in vivo and the feasibility to perform unbiased genetic and pharmacological screens are some of the most prominent advantages of the fruitfly. In this work, we will pay special attention to the most important results reported in fly models to unveil the role of copper and zinc in cellular degeneration and their influence in the development and progression of human neurodegenerative pathologies such as Parkinson's disease, Alzheimer's disease, Huntington's disease, Friedreich's Ataxia or Menkes, and Wilson's diseases. Finally, we show how these studies performed in the fly have allowed to give further insight into the influence of copper and zinc in the molecular and cellular causes and consequences underlying these diseases as well as the discovery of new therapeutic strategies, which had not yet been described in other model systems.Entities:
Keywords: Drosophila melanogaster; copper; dMTF-1; human diseases; in vivo modeling; metal homeostasis; methallothioneins; zinc
Year: 2017 PMID: 29312444 PMCID: PMC5743009 DOI: 10.3389/fgene.2017.00223
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Drosophila proteins involved in Cu homeostasis (names according to Flybase, http://flybase.org).
| Control of metal-dependent transcription of Mtns and some Cu, Zn and iron genes | AD (Hua et al., | ||
| Cellular metal (mainly Cu) detoxification | FRDA (Soriano et al., | ||
| Cellular Cu uptake | AD (Lang et al., | ||
| Cellular Cu export | AD (Lang et al., | ||
| Chaperone. Cu delivery to DmATP7 | AD (Sanokawa-Akakura et al., | ||
| Chaperone. Cu delivery to SOD1 | Not tested | ||
| Chaperone. Cu delivery to cytochrome c oxidase | Not tested |
Gene symbols for human genes follow the regulation of Human Genome Organization Gene Nomenclature Committee (.
dMTF-1 and Mtns have been added in this table since their main role in Drosophila melanogaster is the detoxification of Cu accumulation. AD, Alzheimer's disease; FRDA, Friedreich's ataxia; HD, Huntington's disease; MD, Menkes disease; PD, Parkinson's disease; WD, Wilson's disease.
Figure 1General scheme of cellular Cu homeostasis in Drosophila melanogaster. ER, Endoplasmic Reticulum; Mito, Mitochondria; TGN, TransGolgi network.
Figure 2General scheme of cellular Zn homeostasis in Drosophila melanogaster. ER, Endoplasmic Reticulum; Mito, Mitochondria; LROs, Lysosomal Related Organelles; TGN, TransGolgi network.
Drosophila proteins involved in Cu homeostasis (names according to Flybase, http://flybase.org).
| Cellular Zn uptake | AD (Lang et al., | ||
| Cytosolic Zn uptake from extracellular matrix and from organelles | FRDA (Soriano et al., | ||
| Cellular Zn export | AD (Huang et al., | ||
| Cytosolic Zn export outside of the cell or into cellular organelles | FRDA (Soriano et al., |
Gene symbols for human genes follow the regulation of Human Genome Organization Gene Nomenclature Committee (.